openPR Logo
Press release

Peptide Based Cancer Therapeutics Market Report: Global Peptide Based Cancer Therapeutics Industry Market Report Examines Latest Trends Analysis and Key Drivers Supporting Growth through 2017-2022 (Key Players: AstraZeneca PLC, Allergan plc, Pfizer Inc.,

07-24-2018 01:47 PM CET | Health & Medicine

Press release from: Fact.MR

Peptide Based Cancer Therapeutics Market Report: Global

Dublin, Ireland, 2018-Jul-24 — Medical research institutes as well as investors in the global pharmaceuticals sector are ramping up their efforts toward development of profound therapeutic drugs for treating cancer. This FactMR report analyzes the expansion of global Peptide Based Cancer Therapeutics Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of FactMR’s report is to analyze the global peptide based cancer therapeutics market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Drug manufacturers, research institutes, and raw material suppliers in the global peptide based cancer therapeutics market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide based cancer therapeutics. 

Download Free Sample Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=179

Peptide based cancer therapeutics are yet to become widespread, but the initial low numbers certainly do not suggest any pessimism in the global market. With new developments in delivery, stability, modifications, and preclinical success, future growth potentials of such cancer therapeutics continue to intensify.  A slew of new peptides with positive preclinical results are entering into clinical trials that are focused on cancer treatment. Moreover, the application base of peptides is steadily expanding to other therapeutic areas as well. In the near future, the global peptide based cancer therapeutics market is likely to be influenced by the rising prevalence of cancer across the globe.

WHO reveals that cancer is one of the leading causes of death worldwide, which accounted for more than 8 million deaths in 2015. Factor as such are expected to play an important role in boosting the popularity of peptide based cancer therapeutics further. In addition, various complications involved in conventional cancer therapeutics as well as the risk of sever side-effects are prompting medical professionals to utilise peptides in tumor and cancer treatment. FactMR’s latest report projects that the global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end, expanding at an impressive CAGR of 9.2% during the forecast period (2017-2022).

Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. At present, there are a number of peptide based cancer therapeutics available in the market.  Incessant medical research on peptides has led to development of several peptide based cancer therapeutics that are showing greater results as compared to conventional cancer therapeutics.

Check Complete Report Here - https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market

In terms of revenues, North America is expected to dominate the global peptide based cancer therapeutics market in 2017 and beyond. The region’s potency in healthcare and a strong presence of various peptide based cancer therapeutic drug manufacturers is supporting the growth of the market in North America. During the forecast period, the market in the region is expected to surge at a robust CAGR.

On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.

Peptide Based Cancer Therapeutics Market Key Players:

FactMR’s report has also profiled key companies that are operating in the global peptide based cancer Therapeutic market, which include AstraZeneca PLC, Allergan plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Abbott, AbbVie Inc., and Valeant Pharmaceuticals International, Inc.

Table of Contents

Global Peptide Based Cancer Therapeutics Market - Executive Summary
Global Peptide Based Cancer Therapeutics Market Overview
2.1. Introduction

       2.1.1. Global Peptide Based Cancer Therapeutics Market Taxonomy

       2.1.2. Global Peptide Based Cancer Therapeutics Market Definition

2.2. Global Peptide Based Cancer Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022

       2.2.1. Global Peptide Based Cancer Therapeutics Market Y-o-Y Growth

2.3. Global Peptide Based Cancer Therapeutics Market Dynamics

2.4. Regulations

2.5. Supply Chain

2.6. Cost Structure

2.7. Average Pricing Analysis

2.8. Epidemiology

2.9. Key Participants Market Presence (Intensity Map) By Region

Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast By Drug, 2012-2022

       3.1.1. Goserelin Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022

                3.1.1.1. Revenue (US$ Mn) Comparison, By Region

                3.1.1.2. Market Share Comparison, By Region

                3.1.1.3. Y-o-Y growth Comparison, By Region

       3.1.2. Bortezomib Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022

                3.1.2.1. Revenue (US$ Mn) Comparison, By Region

                3.1.2.2. Market Share Comparison, By Region

                3.1.2.3. Y-o-Y growth Comparison, By Region

Continued…………………………..

Order a copy of Global Market Research Report Here - https://www.factmr.com/checkout/179/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us -

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Cancer Therapeutics Market Report: Global Peptide Based Cancer Therapeutics Industry Market Report Examines Latest Trends Analysis and Key Drivers Supporting Growth through 2017-2022 (Key Players: AstraZeneca PLC, Allergan plc, Pfizer Inc., here

News-ID: 1143038 • Views:

More Releases from Fact.MR

Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2034: Fact.MR Report
03-29-2024 | Health & Medicine
Fact.MR
Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2 …
The global atrial fibrillation devices market (心房細動装置市場) size stands at a valuation of US$ 6.52 billion in 2024, with forecasts predicting a surge to US$ 24.76 billion by the conclusion of 2034. Sales of atrial fibrillation devices worldwide are expected to witness an impressive compound annual growth rate (CAGR) of 14.3% from 2024 to 2034. In recent years, the global healthcare landscape has witnessed a significant surge in the prevalence of
Canola Oil Market Rising at 3.6% CAGR to Reach US$ 625 Million by 2032
03-29-2024 | Food & Beverage
Fact.MR
Canola Oil Market Rising at 3.6% CAGR to Reach US$ 625 Million by 2032
The canola oil market is expected to grow at a compound annual growth rate (CAGR) of 3.6% through 2032, from an estimated value of US$ 415 million in 2022 to US$ 625 million by the end of 2032. By the end of 2032, Bunge, ADM, and Louis Dreyfus Company are projected to be the top three producers of canola oil, accounting for around 31% of the global market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆
Digital Experience Platform Market Size to Cross US$ 29.5 Billion at 10.2% CAGR by 2032
Digital Experience Platform Market Size to Cross US$ 29.5 Billion at 10.2% CAGR …
The market for digital experience platforms is expected to expand at a remarkable 10.2% CAGR. It is anticipated to increase from US$ 9.9 billion in 2021 to around US$ 29.5 billion by 2032. A deeper level of customer involvement has been achieved through the evolution of digital customer platform integration, which began with content management systems (CMSs) in the 1980s and web experience management (WEM) solutions in the 1990s. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲
Fiber Optic Gyroscope Market to Hit US$ 1,760.9 Million with 6.2% CAGR Growth by 2032
Fiber Optic Gyroscope Market to Hit US$ 1,760.9 Million with 6.2% CAGR Growth by …
The fiber optic gyroscopes market is still expanding due to the need for dependable equipment for military and aerospace applications. With a compound annual growth rate (CAGR) of 6.2%, the global fiber optic gyroscope market is projected to reach a valuation of US$ 968.2 million in 2022 and US$ 1,760.9 million by the end of 2032. The market for fiber optic gyroscopes is anticipated to grow as a result of the

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug